Mary Lester
Physician Assistant · Princeton, WVNPI 1750713269
Payments from drug & device makers
Across 77 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$352
- Exact Sciences$104
- Ferring Pharmaceuticals Inc.$94
- Novo Nordisk$91
- Amgen$87
- Abbott$82
- plus $448 from 14 others
What the payments were for
- Food & beverage$1,259100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 24 | $352 |
| Exact Sciences | 5 | $104 |
| Ferring Pharmaceuticals Inc. | 5 | $94 |
| Novo Nordisk | 6 | $91 |
| Amgen | 6 | $87 |
| Abbott | 4 | $82 |
| AbbVie | 5 | $80 |
| Boehringer Ingelheim | 4 | $58 |
| Dexcom, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Optinose US, Inc. | 2 | $31 |
| Pfizer | 2 | $30 |
| Genentech USA, Inc. | 2 | $28 |
| Alkermes, Inc. | 1 | $26 |
| GSK | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
How this compares
$1,259 in reported general payments places this provider in the 75th percentile of 833 physician assistant providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 30 | $49,619 |
| EliquisApixaban | 55 | $47,972 |
| OzempicSemaglutide | 35 | $43,813 |
| MounjaroTirzepatide | 25 | $36,001 |
| JardianceEmpagliflozin | 29 | $33,713 |
| TradjentaLinagliptin | 39 | $30,149 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $12,451 |
| JanuviaSitagliptin Phosphate | 13 | $11,492 |
| Dexlansoprazole DrDexlansoprazole | 14 | $5,264 |
| SynthroidLevothyroxine Sodium | 37 | $2,990 |
| Levothyroxine Sodium | 310 | $2,864 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,343 |
| Omeprazole | 155 | $1,342 |
| Celecoxib | 32 | $1,255 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $352 | $85,62155 claims |
| Boehringer IngelheimJardiance, Tradjenta | $58 | $63,86268 claims |
| PfizerEliquis | $30 | $47,97255 claims |
| Novo NordiskOzempic | $91 | $43,81335 claims |
| GSKTrelegy Ellipta | $22 | $12,45112 claims |
| AbbVieSynthroid | $80 | $2,99037 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Princeton
- Jennifer RiffePrinceton$9K
- Heather CookPrinceton$6K
- Erika PowellPrinceton$5K
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.